Enasidenib in MDS &Non-proliferative Chronic Myelomonocytic Leukemia w/o IDH2 Mutation
Clinical trial NCT05282459 · COMPLETED
Trial details
- NCT number
- NCT05282459
- Sponsor
- Tian Yi Zhang
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-12
- Primary completion
- 2024-12-03
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.